Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma

NCT00481832 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

50

Enrollment

OTHER

Sponsor class

Stopped Accrual Factor

Conditions

Lymphoma, Non-Hodgkin

Interventions

DRUG: Cyclophosphamide
DRUG: BCNU
DRUG: Etoposide
DRUG: Filgrastim
DRUG: Antithymocyte globulin
DRUG: Cyclosporine
DRUG: Mycophenolate mofetil
DRUG: Rituximab
PROCEDURE: Autologous hematopoietic stem cell transplantation (auto-HSCT)
PROCEDURE: Allogeneic hematopoietic stem cell transplantation (allo-HSCT)
PROCEDURE: Total lymphoid irradiation
DRUG: CD34+ Cells
DRUG: Solu-Medrol

Sponsor

Stanford University